Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140

  • Chris P. Miller
  • , Maysoun Shomali
  • , C. Richard Lyttle
  • , Louis St L. O'dea
  • , Hillary Herendeen
  • , Kyla Gallacher
  • , Dottie Paquin
  • , Dennis R. Compton
  • , Bishwabhusan Sahoo
  • , Sean A. Kerrigan
  • , Matthew S. Burge
  • , Michael Nickels
  • , Jennifer L. Green
  • , John A. Katzenellenbogen
  • , Alexei Tchesnokov
  • , Gary Hattersley

Research output: Contribution to journalArticlepeer-review

Abstract

This report describes the discovery of RAD140, a potent, orally bioavailable, nonsteroidal selective androgen receptor modulator (SARM). The characterization of RAD140 in several preclinical models of anabolic androgen action is also described.

Original languageEnglish (US)
Pages (from-to)124-129
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume2
Issue number2
DOIs
StatePublished - Feb 10 2011

Keywords

  • Androgen
  • cachexia
  • Herschberger assay
  • oxadiazole
  • primate
  • SARM

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140'. Together they form a unique fingerprint.

Cite this